Blood cells as supercarrier systems for advanced drug delivery

Li, 2019, Recent progress in drug delivery, Acta Pharm Sin B, 9, 1145, 10.1016/j.apsb.2019.08.003 Patra, 2018, Nano based drug delivery systems: recent developments and future prospects, J Nanobiotechnol, 16, 1, 10.1186/s12951-018-0392-8 Tibbitt, 2016, Emerging frontiers in drug delivery, J Am Chem Soc, 138, 704, 10.1021/jacs.5b09974 Liu, 2021, Engineering nanoparticles to overcome the mucus barrier for drug delivery: Design, evaluation and state-of-the-art, Med Drug Discovery, 12, 100110, 10.1016/j.medidd.2021.100110 Lutz, 2019, Cells and cell derivatives as drug carriers for targeted delivery, Med Drug Discovery, 3, 10.1016/j.medidd.2020.100014 Mills, 1999, Targeted drug delivery, Expert Opin Therap Patents, 9, 1499, 10.1517/13543776.9.11.1499 Tilles, 1987, The near-wall excess of platelet-sized particles in blood flow: its dependence on hematocrit and wall shear rate, Microvascular Res, 33, 211, 10.1016/0026-2862(87)90018-5 Ihler, 1973, Enzyme loading of erythrocytes, Proc Natl Acad Sci USA, 70, 2663, 10.1073/pnas.70.9.2663 Hoffman, 1958, Physiological characteristics of human red blood cell ghosts, J Gen Physiol, 42, 9, 10.1085/jgp.42.1.9 Li, 2021, Surface properties of nanoparticles dictate their toxicity by regulating adsorption of humic acid molecules, ACS Sustain Chem Eng, 9, 13705, 10.1021/acssuschemeng.1c02795 Wang, 2020, Controlled release of entrapped nanoparticles from thermoresponsive hydrogels with tunable network characteristics, Soft Matter, 16, 4756, 10.1039/D0SM00207K Lu, 2017, Molecular modeling of transmembrane delivery of paclitaxel by shock waves with nanobubbles, Appl Phys Lett, 110, 10.1063/1.4973592 Samokhin, 1983, Red blood cell targeting to collagen-coated surfaces, FEBS Lett, 154, 257, 10.1016/0014-5793(83)80160-4 Muzykantov, 1985, Targeting of enzyme immobilized on erythrocyte membrane to collagen-coated surface, FEBS Lett, 182, 62, 10.1016/0014-5793(85)81154-6 Muzykantov, 1986, Immunotargeting of erythrocytes-bound streptokinase provides local lysis of a fibrin clot, Biochim Biophys Acta, 884, 355, 10.1016/0304-4165(86)90184-4 Koleva, 2020, Erythrocytes as carriers: from drug delivery to biosensors, Pharmaceutics, 12, 276, 10.3390/pharmaceutics12030276 Chen, 2018, Morphological and mechanical determinants of cellular uptake of deformable nanoparticles, Nanoscale, 10, 11969, 10.1039/C8NR01521J Rechsteiner, 1975, Uptake of proteins by red blood cells, Exp Cell Res, 93, 487, 10.1016/0014-4827(75)90478-4 Antonelli, 2013, New strategies to prolong the in vivo life span of iron-based contrast agents for MRI, PLoS One, 8, 10.1371/journal.pone.0078542 Mambrini, 2017, Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment, Int J Pharm, 517, 175, 10.1016/j.ijpharm.2016.12.011 Lizano, 1998, In vitro study of alcohol dehydrogenase and acetaldehyde dehydrogenase encapsulated into human erythrocytes by an electroporation procedure, Biochim Biophys Acta, 1425, 328, 10.1016/S0304-4165(98)00085-3 Yamagata, 2008, Encapsulation of concentrated protein into erythrocyte porated by continuous-wave ultrasound, Ultrasound Med Biol, 34, 1924, 10.1016/j.ultrasmedbio.2008.05.001 Ginn, 1969, Membrane alterations in hemolysis: Internalization of plasmalemma induced by primaquine, Science, 164, 843, 10.1126/science.164.3881.843 Ben-Bassat, 1972, Drug-induced erythrocyte membrane internalization, J Clin Invest, 51, 1833, 10.1172/JCI106985 Matovcik, 1985, Drug-induced endocytosis of neonatal erythrocytes, Blood, 65, 1056, 10.1182/blood.V65.5.1056.1056 Kwon, 2009, L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL), J Control Release, 139, 182, 10.1016/j.jconrel.2009.06.027 Tonetti, 1990, Construction and characterization of adriamycin-loaded canine red blood cells as a potential slow delivery system, Biotechnol Appl Biochem, 12, 621, 10.1111/j.1470-8744.1990.tb00136.x Matherne, 1994, Clinical efficacy and toxicity of doxorubicin encapsulated in glutaraldehyde-treated erythrocytes administered to dogs with lymphosarcoma, Am J Vet Res, 55, 847 Lucas, 2019, Doxorubicin-loaded red blood cells reduced cardiac toxicity and preserved anticancer activity, Drug Delivery, 26, 433, 10.1080/10717544.2019.1591544 Magnani, 1989, Human red blood cells as bioreactors for the release of 2’, 3’-dideoxycytidine, an inhibitor of HIV infectivity, Biochem Biophys Res Commun, 164, 446, 10.1016/0006-291X(89)91740-3 Fraternale, 1996, Encapsulation, metabolism and release of 2-fluoro-ara-AMP from human erythrocytes, Biochim Biophys Acta, 1291, 149, 10.1016/0304-4165(96)00059-1 Castro, 2007, Long-term treatment with autologous red blood cells loaded with dexamethasone 21-phosphate in pediatric patients affected by steroid-dependent Crohn disease, J Pediatr Gastroenterol Nutr, 44, 423, 10.1097/MPG.0b013e3180320667 Bossa, 2008, Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study, J Am College Gastroenterol, 103, 2509, 10.1111/j.1572-0241.2008.02103.x Flower, 2008, Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using icg-loaded erythrocyte ghost cells, Invest Ophthalmol Visual Sci, 49, 5510, 10.1167/iovs.07-1504 Markov, 2010, Human erythrocytes as nanoparticle carriers for magnetic particle imaging, Phys Med Biol, 55, 6461, 10.1088/0031-9155/55/21/008 Rossi, 2014, Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pahenu2 mice, J Control Release, 194, 37, 10.1016/j.jconrel.2014.08.012 Yue, 2015, Molecular modeling of interaction between lipid monolayer and graphene nanosheets: Implications for pulmonary nanotoxicity and pulmonary drug delivery, RSC Adv, 5, 30092, 10.1039/C5RA04922A Antonelli, 2016, Characterization of ferucarbotran-loaded RBCs as long circulating magnetic contrast agents, Nanomedicine, 11, 2781 Lu, 2019, Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies, Sci Adv, 5, eaax3905, 10.1126/sciadv.aax3905 Antonelli, 2018, Ferucarbotran-loaded red blood cells as long circulating MRI contrast agents: First in vivo results in mice, Nanomedicine, 13, 675, 10.2217/nnm-2017-0339 Wang, 2018, Surface-modified nanoerythrocyte loading dox for targeted liver cancer chemotherapy, Mol Pharm, 15, 5728, 10.1021/acs.molpharmaceut.8b00881 Jiang, 2018, Doxorubicin-loaded silicon nanoparticles impregnated into red blood cells featuring bright fluorescence, strong photostability, and lengthened blood residency, Nano Res, 11, 2285, 10.1007/s12274-017-1850-6 Hamidi, 2011, Encapsulation of valproate-loaded hydrogel nanoparticles in intact human erythrocytes: a novel nano-cell composite for drug delivery, J Pharm Sci, 100, 1702, 10.1002/jps.22395 Burns, 2018, Erythrocyte-derived theranostic nanoplatforms for near infrared fluorescence imaging and photodestruction of tumors, ACS Appl Mater Interfaces, 10, 27621, 10.1021/acsami.8b08005 Mac, 2016, Erythrocyte-derived nano-probes functionalized with antibodies for targeted near infrared fluorescence imaging of cancer cells, Biomed Opt Express, 7, 1311, 10.1364/BOE.7.001311 Wang, 2019, Fabrication of red blood cell-based multimodal theranostic probes for second near-infrared window fluorescence imaging-guided tumor surgery and photodynamic therapy, Theranostics, 9, 369, 10.7150/thno.29817 DeLoach, 1981, Glutaraldehyde-treated carrier erythrocytes for organ targeting of methotrexate in dogs, Am J Vet Res, 42, 1971 DeLoach, 1983, Hepatic pharmacokinetics of glutaraldehyde-treated methotrexate-loaded carrier erythrocytes in dogs, Res Exp Med, 183, 167, 10.1007/BF01855639 Magnani, 2003, Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression, J Leukoc Biol, 74, 764, 10.1189/jlb.0403156 Rossi, 2008, Prolonged islet allograft survival in diabetic mice upon macrophage depletion by clodronate-loaded erythrocytes, Transplantation, 85, 648, 10.1097/TP.0b013e31816360f3 Cremel, 2015, Innovative approach in pompe disease therapy: Induction of immune tolerance by antigen-encapsulated red blood cells, Int J Pharm, 491, 69, 10.1016/j.ijpharm.2015.05.062 Magnani, 1994, Preparation and characterization of biotinylated red blood cells, Biotechnol Appl Biochem, 20, 335, 10.1111/j.1470-8744.1994.tb00321.x Ganguly, 2005, Blood clearance and activity of erythrocyte-coupled fibrinolytics, J Pharmacol Exp Ther, 312, 1106, 10.1124/jpet.104.075770 Chambers, 2004, Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes, J Control Release, 100, 111, 10.1016/j.jconrel.2004.08.005 Zhao, 2019, Erythrocyte leveraged chemotherapy (ELeCt): Nanoparticle assembly on erythrocyte surface to combat lung metastasis, Sci Adv, 5, eaax9250, 10.1126/sciadv.aax9250 Brenner, 2018, Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude, Nat Commun, 9, 2684, 10.1038/s41467-018-05079-7 Anselmo, 2013, Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells, ACS Nano, 7, 11129, 10.1021/nn404853z Zaitsev, 2006, Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis, Blood, 108, 1895, 10.1182/blood-2005-11-012336 Kontos, 2010, Improving protein pharmacokinetics by engineering erythrocyte affinity, Mol Pharm, 7, 2141, 10.1021/mp1001697 Zaitsev, 2010, Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis, J Pharmacol Exp Ther, 332, 1022, 10.1124/jpet.109.159194 Zaitsev, 2012, Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis, Blood, 119, 4779, 10.1182/blood-2011-12-398149 Villa, 2018, Biocompatible coupling of therapeutic fusion proteins to human erythrocytes, Blood Adv, 2, 165, 10.1182/bloodadvances.2017011734 Huang, 2017, Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin, Nat Commun, 8, 423, 10.1038/s41467-017-00448-0 Pishesha, 2017, Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease, Proc Natl Acad Sci USA, 114, 3157, 10.1073/pnas.1701746114 Wibroe, 2017, Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes, Nat Nanotechnol, 12, 589, 10.1038/nnano.2017.47 Stein, 2009, Erythrocyte-bound tissue plasminogen activator is neuroprotective in experimental traumatic brain injury, J Neurotrauma, 26, 1585, 10.1089/neu.2008.0720 Smirnov, 1986, Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall, Proc Natl Acad Sci USA, 83, 6603, 10.1073/pnas.83.17.6603 Glukhova, 1986, Red blood cell targeting to smooth muscle cells, FEBS Lett, 198, 155, 10.1016/0014-5793(86)81203-0 Gersh, 2010, The spatial dynamics of fibrin clot dissolution catalyzed by erythrocyte-bound vs. free fibrinolytics, J Thromb Haemost, 8, 1066, 10.1111/j.1538-7836.2010.03802.x Gersh, 2011, Flow-dependent channel formation in clots by an erythrocyte-bound fibrinolytic agent, Blood, 117, 4964, 10.1182/blood-2010-10-310409 Pisapia, 2012, Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan, Exp Neurol, 233, 357, 10.1016/j.expneurol.2011.10.029 Murciano, 2009, Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile, J Control Release, 139, 190, 10.1016/j.jconrel.2009.07.003 Armstead, 2010, Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA for treatment of CNS ischemic disorders, J Neurochem, 113, 303, 10.1111/j.1471-4159.2010.06613.x Atukorale, 2015, Influence of the glycocalyx and plasma membrane composition on amphiphilic gold nanoparticle association with erythrocytes, Nanoscale, 7, 11420, 10.1039/C5NR01355K Ganguly, 2007, The glycocalyx protects erythrocyte-bound tissue-type plasminogen activator from enzymatic inhibition, J Pharmacol Exp Ther, 321, 158, 10.1124/jpet.106.114405 Chambers, 2007, Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation, Exp Biol Med, 232, 958 Chen, 2016, Co-assembly of heparin and polypeptide hybrid nanoparticles for biomimetic delivery and anti-thrombus therapy, Small, 12, 4719, 10.1002/smll.201600328 Ukidve, 2020, Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function, Proc Natl Acad Sci USA, 117, 17727, 10.1073/pnas.2002880117 Chiarantini, 1997, Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice, Vaccine, 15, 276, 10.1016/S0264-410X(96)00181-8 Sabatino, 2014, Macrophage depletion by free bisphosphonates and zoledronate-loaded red blood cells, PLoS One, 9, 10.1371/journal.pone.0101260 Biagiotti, 2011, Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs, J Control Release, 154, 306, 10.1016/j.jconrel.2011.05.024 Boberg, 2007, Immunization with HIV protease peptides linked to syngeneic erythrocytes, Infect Agents Cancer, 2, 9, 10.1186/1750-9378-2-9 Magnani, 1992, Red blood cells as an antigen-delivery system, Biotechnol Appl Biochem, 16, 188, 10.1111/j.1470-8744.1992.tb00221.x Grimm, 2015, Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens, Scientific Rep, 5, 15907, 10.1038/srep15907 Lorentz, 2015, Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase, Sci Adv, 1, 10.1126/sciadv.1500112 Oldenborg, 2000, Role of CD47 as a marker of self on red blood cells, Science, 288, 2051, 10.1126/science.288.5473.2051 Xia, 2019, Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application, Acta Pharm Sin B, 9, 675, 10.1016/j.apsb.2019.01.011 Wang, 2019, Penetration of nanoparticles across a lipid bilayer: effects of particle stiffness and surface hydrophobicity, Nanoscale, 11, 4025, 10.1039/C8NR09381D Tajerzadeh, 2000, Evaluation of hypotonic preswelling method for encapsulation of enalaprilat in intact human erythrocytes, Drug Dev Ind Pharm, 26, 1247, 10.1081/DDC-100102306 Lynch, 2011, Ph-responsive polymers for trehalose loading and desiccation protection of human red blood cells, Biomaterials, 32, 4443, 10.1016/j.biomaterials.2011.02.062 Ren, 2016, Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy, Biomaterials, 92, 13, 10.1016/j.biomaterials.2016.03.026 Hu, 2011, Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform, Proc Natl Acad Sci USA, 108, 10980, 10.1073/pnas.1106634108 Zhai, 2017, Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy, Theranostics, 7, 2575, 10.7150/thno.20118 Su, 2016, Long circulation red-blood-cell-mimetic nanoparticles with peptide-enhanced tumor penetration for simultaneously inhibiting growth and lung metastasis of breast cancer, Adv Funct Mater, 26, 1243, 10.1002/adfm.201504780 Luk, 2014, Interfacial interactions between natural rbc membranes and synthetic polymeric nanoparticles, Nanoscale, 6, 2730, 10.1039/C3NR06371B Rao, 2017, Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy, ACS Nano, 11, 3496, 10.1021/acsnano.7b00133 Zhang, 2015, Synthesis of nanogels via cell membrane-templated polymerization, Small, 11, 4309, 10.1002/smll.201500987 Su, 2016, Bioinspired nanoparticles with NIR-controlled drug release for synergetic chemophotothermal therapy of metastatic breast cancer, Adv Funct Mater, 26, 7495, 10.1002/adfm.201603381 Rao, 2015, Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance, Small, 11, 6225, 10.1002/smll.201502388 Shen, 2015, Magnetic nanoparticle clusters for photothermal therapy with near-infrared irradiation, Biomaterials, 39, 67, 10.1016/j.biomaterials.2014.10.064 Su, 2017, Enhanced blood suspensibility and laser-activated tumor-specific drug release of theranostic mesoporous silica nanoparticles by functionalizing with erythrocyte membranes, Theranostics, 7, 523, 10.7150/thno.17259 Vernier, 2009, Electroporating fields target oxidatively damaged areas in the cell membrane, PLoS One, 4, 10.1371/journal.pone.0007966 Ding, 2015, Erythrocyte membrane-coated NIR-triggered biomimetic nanovectors with programmed delivery for photodynamic therapy of cancer, Nanoscale, 7, 9806, 10.1039/C5NR02470F Piao, 2014, Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy, ACS Nano, 8, 10414, 10.1021/nn503779d Li, 2014, Core-shell supramolecular gelatin nanoparticles for adaptive and “on-demand antibiotic delivery, ACS Nano, 8, 4975, 10.1021/nn501040h Wang, 2014, Multifunctional theranostic red blood cells for magnetic-field-enhanced in vivo combination therapy of cancer, Adv Mater, 26, 4794, 10.1002/adma.201400158 Gao, 2013, Surface functionalization of gold nanoparticles with red blood cell membranes, Adv Mater, 25, 3549, 10.1002/adma.201300638 Dehaini, 2017, Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization, Adv Mater, 29, 1606209, 10.1002/adma.201606209 Fang, 2013, Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles, Nanoscale, 5, 8884, 10.1039/c3nr03064d Jahromi, 2021, Chemically engineered immune cell-derived microrobots and biomimetic nanoparticles: Emerging biodiagnostic and therapeutic tools, Adv Sci, 8, 2002499, 10.1002/advs.202002499 Li, 2021, From blood to brain: blood cell-based biomimetic drug delivery systems, Drug Delivery, 1214, 10.1080/10717544.2021.1937384 Mitchell, 2015, Leukocytes as carriers for targeted cancer drug delivery, Expert Opin Drug Deliv, 12, 375, 10.1517/17425247.2015.966684 Choi, 2007, A cellular trojan horse for delivery of therapeutic nanoparticles into tumors, Nano Lett, 7, 3759, 10.1021/nl072209h Hou, 2019, Accessing neuroinflammation sites: Monocyte/neutrophil-mediated drug delivery for cerebral ischemia, Sci Adv, 5, eaau8301, 10.1126/sciadv.aau8301 Xue, 2017, Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence, Nat Nanotechnol, 12, 692, 10.1038/nnano.2017.54 Xia, 2020, Engineering macrophages for cancer immunotherapy and drug delivery, Adv Mater, 32, 2002054, 10.1002/adma.202002054 Evans, 2020, Macrophage-mediated delivery of hypoxia-activated prodrug nanoparticles, Adv Therap, 3, 1900162, 10.1002/adtp.201900162 Zhang, 2018, Nanoparticle-laden macrophages for tumor-tropic drug delivery, Adv Mater, 30, 1805557, 10.1002/adma.201805557 Guo, 2019, Tunneling nanotubular expressways for ultrafast and accurate M1 macrophage delivery of anticancer drugs to metastatic ovarian carcinoma, ACS Nano, 13, 1078 Pang, 2018, Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy, Drug Delivery, 25, 1922, 10.1080/10717544.2018.1502839 Li, 2019, Artificially reprogrammed macrophages as tumor-tropic immunosuppression-resistant biologics to realize therapeutics production and immune activation, Adv Mater, 31, 1807211, 10.1002/adma.201807211 He, 2017, Inflammatory monocytes loading protease-sensitive nanoparticles enable lung metastasis targeting and intelligent drug release for anti-metastasis therapy, Nano Lett, 17, 5546, 10.1021/acs.nanolett.7b02330 Lee, 2014, Monocytes: a novel drug delivery system targeting atherosclerosis, J Drug Target, 22, 138, 10.3109/1061186X.2013.844158 Zheng, 2019, In vivo monocyte/macrophage-hitchhiked intratumoral accumulation of nanomedicines for enhanced tumor therapy, J Am Chem Soc, 142, 382, 10.1021/jacs.9b11046 Huang, 2015, Monocytic delivery of therapeutic oxygen bubbles for dual-modality treatment of tumor hypoxia, J Control Release, 220, 738, 10.1016/j.jconrel.2015.09.016 Huang, 2015, Tumortropic monocyte-mediated delivery of echogenic polymer bubbles and therapeutic vesicles for chemotherapy of tumor hypoxia, Biomaterials, 71, 71, 10.1016/j.biomaterials.2015.08.033 Lang, 2017, Ly6Chi monocytes delivering pH-sensitive micelle loading paclitaxel improve targeting therapy of metastatic breast cancer, Adv Funct Mater, 27, 1701093, 10.1002/adfm.201701093 Li, 2017, Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses, Immunology, 152, 462, 10.1111/imm.12783 D’Elios, 2018, Myelin-specific T cells carry and release magnetite PGLA-PEG COOH nanoparticles in the mouse central nervous system, RSC Adv, 8, 904, 10.1039/C7RA11290D Mühlberger, 2019, Functionalization of T lymphocytes for magnetically controlled immune therapy: Selection of suitable superparamagnetic iron oxide nanoparticles, J Magn Magn Mater, 473, 61, 10.1016/j.jmmm.2018.10.022 Jiang, 2020, Engineered cell-membrane-coated nanoparticles directly present tumor antigens to promote anticancer immunity, Adv Mater, 32, 2001808, 10.1002/adma.202001808 Cao, 2018, Bioengineered macrophages can responsively transform into nanovesicles to target lung metastasis, Nano Lett, 18, 4762, 10.1021/acs.nanolett.8b01236 Alvey, 2017, Sirpa-inhibited, marrow-derived macrophages engorge, accumulate, and differentiate in antibody-targeted regression of solid tumors, Curr Biol, 27, 2065, 10.1016/j.cub.2017.06.005 Qin, 2015, Monocyte mediated brain targeting delivery of macromolecular drug for the therapy of depression, Nanomedicine, 11, 391, 10.1016/j.nano.2014.09.012 Wang, 2018, Monocyte-mediated chemotherapy drug delivery in glioblastoma, Nanomedicine, 13, 157, 10.2217/nnm-2017-0266 Burga, 2016, Conjugating prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapy, Nanomedicine, 11, 1759, 10.2217/nnm-2016-0160 Wayteck, 2016, Hitchhiking nanoparticles: Reversible coupling of lipid-based nanoparticles to cytotoxic T lymphocytes, Biomaterials, 77, 243, 10.1016/j.biomaterials.2015.11.016 Tang, 2018, Enhancing T cell therapy through tcr-signaling-responsive nanoparticle drug delivery, Nat Biotechnol, 36, 707, 10.1038/nbt.4181 Chen, 2019, Photothermal therapy promotes tumor infiltration and antitumor activity of car T cells, Adv Mater, 31, 1900192, 10.1002/adma.201900192 Smith, 2017, Biopolymers codelivering engineered T cells and sting agonists can eliminate heterogeneous tumors, J Clin Invest, 127, 2176, 10.1172/JCI87624 Wang, 2021, White blood cell membrane-coated nanoparticles, 2101349 Wan, 2018, Aptamer-conjugated extracellular nanovesicles for targeted drug delivery, Cancer Res, 78, 798, 10.1158/0008-5472.CAN-17-2880 Dong, 2019, Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke, ACS Nano, 13, 1272 Xuan, 2015, Macrophage cell membrane camouflaged mesoporous silica nanocapsules for in vivo cancer therapy, Adv Healthcare Mater, 4, 1645, 10.1002/adhm.201500129 Hu, 2020, Phagocyte-membrane-coated and laser-responsive nanoparticles control primary and metastatic cancer by inducing anti-tumor immunity, Biomaterials, 255, 10.1016/j.biomaterials.2020.120159 Choo, 2018, M1 macrophage-derived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors, ACS Nano, 12, 8977, 10.1021/acsnano.8b02446 Song, 2019, M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124, Theranostics, 9, 2910, 10.7150/thno.30879 Campbell, 2021, Cd4+ T cell-mimicking nanoparticles encapsulating diablo/smac mimetics broadly neutralize HIV-1 and selectively kill HIV-1-infected cells, Theranostics, 11, 9009, 10.7150/thno.59728 Ai, 2020, Emerging approaches to functionalizing cell membrane-coated nanoparticles, Biochemistry, 60, 941, 10.1021/acs.biochem.0c00343 Rao, 2018, Platelet-facilitated photothermal therapy of head and neck squamous cell carcinoma, Angew Chem, 130, 998, 10.1002/ange.201709457 He, 2018, Leutusome: A biomimetic nanoplatform integrating plasma membrane components of leukocytes and tumor cells for remarkably enhanced solid tumor homing, Nano Lett, 18, 6164, 10.1021/acs.nanolett.8b01892 Ding, 2020, Multivalent aptamer functionalized Ag2S nanodots/hybrid cell membrane-coated magnetic nanobioprobe for the ultrasensitive isolation and detection of circulating tumor cells, Adv Funct Mater, 30, 1909781, 10.1002/adfm.201909781 Liu, 2019, Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells, Nat Commun, 10, 1 Liu, 2019, Expandable immunotherapeutic nanoplatforms engineered from cytomembranes of hybrid cells derived from cancer and dendritic cells, Adv Mater, 31, 1900499, 10.1002/adma.201900499 Gong, 2020, Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy, J Nanobiotechnol, 18, 92, 10.1186/s12951-020-00649-8 Ye, 2020, Nanosponges of circulating tumor-derived exosomes for breast cancer metastasis inhibition, Biomaterials, 242, 10.1016/j.biomaterials.2020.119932 Mackman, 2008, Triggers, targets and treatments for thrombosis, Nature, 451, 914, 10.1038/nature06797 Sekhon, 2017, Platelets and platelet-inspired biomaterials technologies in wound healing applications, ACS Biomater Sci Eng, 4, 1176, 10.1021/acsbiomaterials.7b00013 Xu, 2018, Cancer and platelet crosstalk: Opportunities and challenges for aspirin and other antiplatelet agents, Blood J Am Soc Hematol, 131, 1777 Franco, 2015, Platelets at the interface of thrombosis, inflammation, and cancer, Blood, 126, 582, 10.1182/blood-2014-08-531582 Olsson, 2005, Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia, Blood, 105, 3577, 10.1182/blood-2004-08-2980 Semple, 2011, Platelets and the immune continuum, Nat Rev Immunol, 11, 264, 10.1038/nri2956 Lu, 2019, Platelet for drug delivery, Curr Opin Biotechnol, 58, 81, 10.1016/j.copbio.2018.11.010 Lievens, 2011, Platelets in atherosclerosis, Thromb Haemost, 106, 827, 10.1160/TH11-08-0592 Jurasz, 2004, Platelet–cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation, Br J Pharmacol, 143, 819, 10.1038/sj.bjp.0706013 Fitzgerald, 2006, The interaction of bacterial pathogens with platelets, Nat Rev Microbiol, 4, 445, 10.1038/nrmicro1425 Yarmush, 2014, Electroporation-based technologies for medicine: principles, applications, and challenges, Annu Rev Biomed Eng, 16, 295, 10.1146/annurev-bioeng-071813-104622 Li, 2016, Platelet-cytokine complex suppresses tumour growth by exploiting intratumoural thrombin-dependent platelet aggregation, Scientific Rep, 6, 25077, 10.1038/srep25077 Jin, 2013, Nanosized aspirin-Arg-Gly-Asp-Val: delivery of aspirin to thrombus by the target carrier Arg-Gly-Asp-Val tetrapeptide, ACS Nano, 7, 7664, 10.1021/nn402171v Shoffstall, 2013, Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma, Biomacromolecules, 14, 2790, 10.1021/bm400619v Zhang, 2018, Cyclic rgd functionalized liposomes encapsulating urokinase for thrombolysis, Acta Biomater, 70, 227, 10.1016/j.actbio.2018.01.038 Bonnard, 2018, Low-fouling and biodegradable protein-based particles for thrombus imaging, ACS Nano, 12, 6988, 10.1021/acsnano.8b02588 Yap, 2017, Targeting activated platelets: a unique and potentially universal approach for cancer imaging, Theranostics, 7, 2565, 10.7150/thno.19900 Li, 2017, Development of polymer microcapsules functionalized with fucoidan to target P-selectin overexpressed in cardiovascular diseases, Adv Healthc Mater, 6, 1601200, 10.1002/adhm.201601200 Juenet, 2018, Thrombolytic therapy based on fucoidan-functionalized polymer nanoparticles targeting p-selectin, Biomaterials, 156, 204, 10.1016/j.biomaterials.2017.11.047 Pan, 2017, Annexin v-conjugated mixed micelles as a potential drug delivery system for targeted thrombolysis, Biomacromolecules, 18, 865, 10.1021/acs.biomac.6b01756 Huang, 2019, An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy, J Control Release, 300, 1, 10.1016/j.jconrel.2019.02.033 Guo, 2021, Fucoidan-functionalized activated platelet-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatment, Acta Pharm Sin B, 121102 Ziegler, 2017, Platelet-targeted delivery of peripheral blood mononuclear cells to the ischemic heart restores cardiac function after ischemia-reperfusion injury, Theranostics, 7, 3192, 10.7150/thno.19698 Wang, 2017, In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy, Nat Biomed Eng, 1, 0011, 10.1038/s41551-016-0011 Hu, 2018, Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy, Nat Biomed Eng, 2, 831, 10.1038/s41551-018-0310-2 Hu, 2016, Engineered nanoplatelets for enhanced treatment of multiple myeloma and thrombus, Adv Mater, 28, 9573, 10.1002/adma.201603463 Li, 2016, Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles, Biomaterials, 76, 52, 10.1016/j.biomaterials.2015.10.046 Xu, 2018, Platelet membrane coating coupled with solar irradiation endows a photodynamic nanosystem with both improved antitumor efficacy and undetectable skin damage, Biomaterials, 159, 59, 10.1016/j.biomaterials.2017.12.028 Wang, 2018, A paradigm of endothelium-protective and stent-free anti-restenotic therapy using biomimetic nanoclusters, Biomaterials, 178, 293, 10.1016/j.biomaterials.2018.06.025 Li, 2018, Biomimetic platelet-camouflaged nanorobots for binding and isolation of biological threats, Adv Mater, 30, 1704800, 10.1002/adma.201704800 Wei, 2016, Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia, Biomaterials, 111, 116, 10.1016/j.biomaterials.2016.10.003 Hu, 2015, Anticancer platelet-mimicking nanovehicles, Adv Mater, 27, 7043, 10.1002/adma.201503323 Hu, 2015, Nanoparticle biointerfacing by platelet membrane cloaking, Nature, 526, 118, 10.1038/nature15373 Wei, 2018, Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis, ACS Nano, 12, 109, 10.1021/acsnano.7b07720 Tang, 2018, Targeted repair of heart injury by stem cells fused with platelet nanovesicles, Nat Biomed Eng, 2, 17, 10.1038/s41551-017-0182-x Balmert, 2012, Biomimetic delivery with micro-and nanoparticles, Adv Mater, 24, 3757, 10.1002/adma.201200224 Petros, 2010, Strategies in the design of nanoparticles for therapeutic applications, Nat Rev Drug Discovery, 9, 615, 10.1038/nrd2591 Yoo, 2011, Bio-inspired, bioengineered and biomimetic drug delivery carriers, Nat Rev Drug Discovery, 10, 521, 10.1038/nrd3499 Merkel, 2011, Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles, Proc Natl Acad Sci USA, 108, 586, 10.1073/pnas.1010013108 She, 2013, Fabrication of red-blood-cell-like polyelectrolyte microcapsules and their deformation and recovery behavior through a microcapillary, Adv Mater, 25, 5814, 10.1002/adma.201302875 Ju, 2017, Red-blood-cell-shaped chitosan microparticles prepared by electrospraying, Particuology, 30, 151, 10.1016/j.partic.2016.05.011 Ou, 2020, Artificial nanoscale erythrocytes from clinically relevant compounds for enhancing cancer immunotherapy, Nano-Micro Lett, 12, 90, 10.1007/s40820-020-00428-y Doshi, 2009, Red blood cell-mimicking synthetic biomaterial particles, Proc Natl Acad Sci USA, 106, 21495, 10.1073/pnas.0907127106 Hosaka, 2014, Hemoglobin–albumin cluster incorporating a Pt nanoparticle: Artificial O2 carrier with antioxidant activities, PLoS One, 9, 10.1371/journal.pone.0110541 Tomita, 2013, Covalent core–shell architecture of hemoglobin and human serum albumin as an artificial O2 carrier, Biomacromolecules, 14, 1816, 10.1021/bm400204y Chen, 2012, Low modulus biomimetic microgel particles with high loading of hemoglobin, Biomacromolecules, 13, 2748, 10.1021/bm3007242 Rameez, 2011, Simple method for preparing poly (ethylene glycol)-surface-conjugated liposome-encapsulated hemoglobins: physicochemical properties, long-term storage stability, and their reactions with O2, CO, and NO, Langmuir, 27, 8829, 10.1021/la201246m Yadav, 2016, Nanovesicular liposome-encapsulated hemoglobin (LEH) prevents multi-organ injuries in a rat model of hemorrhagic shock, Eur J Pharm Sci, 93, 97, 10.1016/j.ejps.2016.08.010 Duan, 2012, Highly loaded hemoglobin spheres as promising artificial oxygen carriers, ACS Nano, 6, 6897, 10.1021/nn301735u Jia, 2012, Construction and evaluation of hemoglobin-based capsules as blood substitutes, Adv Funct Mater, 22, 1446, 10.1002/adfm.201102737 Liu, 2018, Aggressive man-made red blood cells for hypoxia-resistant photodynamic therapy, Adv Mater, 30, 1802006, 10.1002/adma.201802006 Liu, 2018, Erythrocyte membrane bioinspired near-infrared persistent luminescence nanocarriers for in vivo long-circulating bioimaging and drug delivery, Biomaterials, 165, 39, 10.1016/j.biomaterials.2018.02.042 Gao, 2019, Red blood cell-mimicking micromotor for active photodynamic cancer therapy, ACS Appl Mater Interfaces, 11, 23392, 10.1021/acsami.9b07979 Guo, 2020, Biomimetic rebuilding of multifunctional red blood cells: modular design using functional components, ACS Nano, 14, 7847, 10.1021/acsnano.9b08714 Tsai, 2008, Inhibition of self engulfment through deactivation of myosin-II at the phagocytic synapse between human cells, J Cell Biol, 180, 989, 10.1083/jcb.200708043 Rodriguez, 2013, Minimal self peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles, Science, 339, 971, 10.1126/science.1229568 Eniola, 2003, Artificial polymeric cells for targeted drug delivery, J Control Release, 87, 15, 10.1016/S0168-3659(02)00346-2 Eniola, 2005, In vitro characterization of leukocyte mimetic for targeting therapeutics to the endothelium using two receptors, Biomaterials, 26, 7136, 10.1016/j.biomaterials.2005.05.005 Hammer, 2008, Leuko-polymersomes, Faraday Discussions, 139, 129, 10.1039/b717821b Lashof-Sullivan, 2014, Intravenously administered nanoparticles increase survival following blast trauma, Proc Natl Acad Sci USA, 111, 10293, 10.1073/pnas.1406979111 Brunk, 1996, Sialyl Lewis(x)/E-selectin-mediated rolling in a cell-free system, Biophys J, 71, 2902, 10.1016/S0006-3495(96)79487-0 Ahmed, 2017, Neutrophil-inspired propulsion in a combined acoustic and magnetic field, Nat Commun, 8, 770, 10.1038/s41467-017-00845-5 Alapan, 2020, Multifunctional surface microrollers for targeted cargo delivery in physiological blood flow, Sci Robot, 5, eaba5726, 10.1126/scirobotics.aba5726 Choi, 2021, Recent Progress in Magnetically Actuated Microrobots for Targeted Delivery of Therapeutic Agents, Adv Healthc Mater, 10, 2001596, 10.1002/adhm.202001596 Eniola, 2002, Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes, Biomaterials, 23, 2167, 10.1016/S0142-9612(01)00349-0 Sun, 2010, Superior sensitivity of novel molecular imaging probe: simultaneously targeting two types of endothelial injury markers, FASEB J, 24, 1532, 10.1096/fj.09-148981 Zhou, 2021, Magnetically Driven Micro and Nanorobots, Chem Rev, 121, 4999, 10.1021/acs.chemrev.0c01234 Bozuyuk, 2021, Shape anisotropy-governed locomotion of surface microrollers on vessel-like microtopographies against physiological flows, Proc Natl Acad Sci USA, 118, 10.1073/pnas.2022090118 Tasci, 2016, Surface-enabled propulsion and control of colloidal microwheels, Nat Commun, 10225, 10.1038/ncomms10225 Qi, 2021, Quantitative prediction of rolling dynamics of leukocyte-inspired microroller in blood flow, Phys Fluids, 33, 10.1063/5.0072842 Sen Gupta, 2017, Bio-inspired nanomedicine strategies for artificial blood components, Wiley Interdiscip Rev: Nanomed Nanobiotechnol, 9 Slack, 1981, Acute hemodynamic effects and blood pool kinetics of polystyrene microspheres following intravenous administration, J Pharm Sci, 70, 660, 10.1002/jps.2600700621 Eckstein, 1988, Conditions for the occurrence of large near-wall excesses of small particles during blood flow, Microvasc Res, 36, 31, 10.1016/0026-2862(88)90036-2 Charoenphol, 2010, Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers, Biomaterials, 31, 1392, 10.1016/j.biomaterials.2009.11.007 Decuzzi, 2010, Size and shape effects in the biodistribution of intravascularly injected particles, J Control Release, 141, 320, 10.1016/j.jconrel.2009.10.014 Thompson, 2013, The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow, Biomaterials, 34, 5863, 10.1016/j.biomaterials.2013.04.011 Müller, 2014, Margination of micro- and nano-particles in blood flow and its effect on drug delivery, Scientific Rep, 4, 4871, 10.1038/srep04871 Geng, 2007, Shape effects of filaments versus spherical particles in flow and drug delivery, Nat Nanotechnol, 2, 249, 10.1038/nnano.2007.70 Decuzzi, 2006, The adhesive strength of non-spherical particles mediated by specific interactions, Biomaterials, 27, 5307, 10.1016/j.biomaterials.2006.05.024 Decuzzi, 2008, The receptor-mediated endocytosis of nonspherical particles, Biophys J, 94, 3790, 10.1529/biophysj.107.120238 Saxena, 2013, Zirconium phosphate nanoplatelets: A biocompatible nanomaterial for drug delivery to cancer, Nanoscale, 5, 2328, 10.1039/c3nr34242e Simberg, 2007, Biomimetic amplification of nanoparticle homing to tumors, Proc Natl Acad Sci USA, 104, 932, 10.1073/pnas.0610298104 Brown, 2014, Ultrasoft microgels displaying emergent platelet-like behaviours, Nat Mater, 13, 1108, 10.1038/nmat4066 Todd, 2021, Platelet-like particles reduce coagulopathy-related and neuroinflammatory pathologies post-experimental traumatic brain injury, J Biomed Mater Res Part B, 109, 2268, 10.1002/jbm.b.34888 Takeoka, 2002, Rolling properties of rGPIBα-conjugated phospholipid vesicles with different membrane flexibilities on vWf surface under flow conditions, Biochem Biophys Res Commun, 296, 765, 10.1016/S0006-291X(02)00934-8 Anselmo, 2014, Platelet-like nanoparticles: Mimicking shape, flexibility, and surface biology of platelets to target vascular injuries, ACS Nano, 8, 11243, 10.1021/nn503732m Hickman, 2018, Intravenous synthetic platelet (SynthoPlate) nanoconstructs reduce bleeding and improve ’golden hour’ survival in a porcine model of traumatic arterial hemorrhage, Scientific Rep, 8, 3118, 10.1038/s41598-018-21384-z Yang, 2020, A biomimetic platelet based on assembling peptides initiates artificial coagulation, Sci Adv, 6, eaaz4107, 10.1126/sciadv.aaz4107 Liu, 2006, Immersed finite element method and its applications to biological systems, Comput Methods Appl Mech Eng, 195, 1722, 10.1016/j.cma.2005.05.049 Peng, 2011, Multiscale modelling of erythrocytes in stokes flow, J Fluid Mech, 686, 299, 10.1017/jfm.2011.332 Reasor, 2012, Coupling the lattice-boltzmann and spectrin-link methods for the direct numerical simulation of cellular blood flow, Int J Numer Meth Fluids, 68, 767, 10.1002/fld.2534 Wang, 2014, A quasi-continuum model for human erythrocyte membrane based on the higher order cauchyborn rule, Comput Methods Appl Mech Eng, 268, 284, 10.1016/j.cma.2013.08.020 Liu, 2020, Heterogeneous partition of cellular blood-borne nanoparticles through microvascular bifurcations, Phys Rev E, 102, 10.1103/PhysRevE.102.013310 Dharmavaram, 2021, A gauge-fixing procedure for spherical fluid membranes and application to computations, Comput Methods Appl Mech Eng, 381, 10.1016/j.cma.2021.113849 Li, 2007, Cytoskeletal dynamics of human erythrocyte, Proc Natl Acad Sci USA, 104, 4937, 10.1073/pnas.0700257104 Pivkin, 2008, Accurate coarse-grained modeling of red blood cells, Phys Rev Lett, 101, 10.1103/PhysRevLett.101.118105 Hosseini, 2009, A particle-based model for the transport of erythrocytes in capillaries, Chem Eng Sci, 64, 4488, 10.1016/j.ces.2008.11.028 Fedosov, 2010, Systematic coarse-graining of spectrin-level red blood cell models, Comput Methods Appl Mech Eng, 199, 1937, 10.1016/j.cma.2010.02.001 Li, 2012, Two-component coarse-grained molecular-dynamics model for the human erythrocyte membrane, Biophys J, 102, 75, 10.1016/j.bpj.2011.11.4012 Li, 2013, Continuum- and particle-based modeling of shapes and dynamics of red blood cells in health and disease, Soft Matter, 9, 28, 10.1039/C2SM26891D Peng, 2013, Lipid bilayer and cytoskeletal interactions in a red blood cell, Proc Natl Acad Sci USA, 110, 13356, 10.1073/pnas.1311827110 Li, 2014, Erythrocyte membrane model with explicit description of the lipid bilayer and the spectrin network, Biophys J, 107, 642, 10.1016/j.bpj.2014.06.031 Zhang, 2015, Multiple stiffening effects of nanoscale knobs on human red blood cells infected with Plasmodium falciparum malaria parasite, Proc Natl Acad Sci USA, 112, 6068, 10.1073/pnas.1505584112 Ye, 2016, Particle-based simulations of red blood cellsA review, J Biomech, 49, 2255, 10.1016/j.jbiomech.2015.11.050 Tang, 2017, Openrbc: A fast simulator of red blood cells at protein resolution, Biophys J, 112, 2030, 10.1016/j.bpj.2017.04.020 Ademiloye, 2018, A multiscale framework for large deformation modeling of RBC membranes, Comput Methods Appl Mech Eng, 329, 144, 10.1016/j.cma.2017.10.004 Li, 2018, Mechanics of diseased red blood cells in human spleen and consequences for hereditary blood disorders, Proc Natl Acad Sci USA, 115, 9574, 10.1073/pnas.1806501115 Li, 2018, Cytoskeleton remodeling induces membrane stiffness and stability changes of maturing reticulocytes, Biophys J, 114, 2014, 10.1016/j.bpj.2018.03.004 Bian, 2020, Bending models of lipid bilayer membranes: Spontaneous curvature and area-difference elasticity, Comput Methods Appl Mech Eng, 359, 10.1016/j.cma.2019.112758 Li, 2021, How the spleen reshapes and retains young and old red blood cells: A computational investigation, PLoS Comput Biol, 17, 10.1371/journal.pcbi.1009516 Saltzman, 1991, Drugs released from polymers: diffusion and elimination in brain tissue, Chem Eng Sci, 46, 2429, 10.1016/0009-2509(91)80036-X Li, 2014, Construction of dissipative particle dynamics models for complex fluids via the moriz-wanzig formulation, Soft Matter, 10, 8659, 10.1039/C4SM01387E Lu, 2019, Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies, Sci Adv, 5, eaax3905, 10.1126/sciadv.aax3905 Yang, 2010, Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer, Nat Nanotechnol, 5, 579, 10.1038/nnano.2010.141 Hui, 2020, Nanoparticle elasticity regulates phagocytosis and cancer cell uptake, Sci Adv, 6, eaaz4316, 10.1126/sciadv.aaz4316 Xiu, 2003, Modeling uncertainty in flow simulations via generalized polynomial chaos, J Comput Phys, 187, 137, 10.1016/S0021-9991(03)00092-5 Zhang, 2019, Quantifying total uncertainty in physics-informed neural networks for solving forward and inverse stochastic problems, J Comput Phys, 397, 10.1016/j.jcp.2019.07.048 Lee, 2014, Quantifying uncertainties in the microvascular transport of nanoparticles, Biomech Model Mechanobiol, 13, 515, 10.1007/s10237-013-0513-0 Pereira, 2013, On the uncertainty quantification of blood flow viscosity models, Chem Eng Sci, 101, 253, 10.1016/j.ces.2013.05.033 Lu, 2017, Sensitivity analysis and uncertainty quantification in pulmonary drug delivery of orally inhaled pharmaceuticals, J Pharm Sci, 106, 3303, 10.1016/j.xphs.2017.06.011 Economides, 2021, Hierarchical bayesian uncertainty quantification for a model of the red blood cell, Phys Rev Appl, 15, 10.1103/PhysRevApplied.15.034062 Chessa, 2014, Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trial, Orphanet J Rare Diseases, 9, 5, 10.1186/1750-1172-9-5 Leuzzi, 2015, Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia, Neurol-Neuroimmunol Neuroinflamm, 2, 10.1212/NXI.0000000000000098 Hunault-Berger, 2015, AP hase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with P hiladelphia chromosome negative acute lymphoblastic leukemia: the GRASPALL/GRAALL-SA 2–2008 study, Am J Hematol, 90, 811, 10.1002/ajh.24093 Bachet, 2015, Asparagine synthetase expression and phase I study with L-Asparaginase encapsulated in red blood cells in patients with pancreatic adenocarcinoma, Pancreas, 44, 1141, 10.1097/MPA.0000000000000394 Dolgin, 2017, Epic $12 billion deal and FDA’s approval raise CAR-T to new heights, Nat Biotechnol, 35, 891, 10.1038/nbt1017-891 Hartmann, 2017, Clinical development of car T cellschallenges and opportunities in translating innovative treatment concepts, EMBO Mol Med, 9, 1183, 10.15252/emmm.201607485 Dolberg, 2018, Reframing cell therapy for cancer, Nat Chem Biol, 14, 204, 10.1038/nchembio.2573 Sukumaran, 2018, Enhancing the potency and specificity of engineered T cells for cancer treatment, Cancer Discovery, 8, 972, 10.1158/2159-8290.CD-17-1298 Li, 2017, Biomechanics and biorheology of red blood cells in sickle cell anemia, J Biomech, 50, 34, 10.1016/j.jbiomech.2016.11.022